23andMe AI Market Strategy Report - DNA Testing Kits
This report supports CiteWorks Studio's examination of how AI search is recommending DNA Testing Kits. For more detail, you can also read DNA Testing Kits: AI Discovery Index.
On this report
Browse sections
- Answer Capsule
- Who This Report Is For
- Report Card
- Executive Summary
- What 23andMe Is Winning
- Where 23andMe Has the Clearest AI Visibility Gaps
- Biggest Opportunity
- Competitive Landscape
- Prompt Evidence
- What CiteWorks Studio Would Do Next
- Why This Matters
- Core Metrics
- Sentiment Score
- Sentiment by Platform
- Methodology
- See How AI Is Recommending Your Brand
- Next Step
- Learn More
Key Takeaways
- 23andMe ranked second in DNA testing kits with 65.15% valid recommendation coverage, trailing AncestryDNA by 8.2 percentage points.
- The brand appeared in 95.6% of qualified AI responses, showing broad visibility, but converted that presence into rank-one placement only 1.3% of the time.
- Top-three placement declined from 67.5% in July to 58.14% in September, indicating weaker recommendation conversion over the three-month period.
- Perplexity and ChatGPT showed the strongest top-three performance for 23andMe, while Copilot and Gemini recorded zero rank-one placements.
Answer Capsule
23andMe holds the second-strongest recommendation position in the DNA testing kits category with valid recommendation coverage of 65.15% in September 2026, trailing category leader AncestryDNA by 8.2 percentage points. The brand is highly visible, present in 95.6% of qualified AI responses, but its recommendation conversion has weakened across the three-month benchmark series. The clearest vulnerability is placement: 23andMe appears in the top three in 58.14% of observations but is the first-listed recommendation only 1.3% of the time, a sharp contrast with AncestryDNA's 67.1% rank-one rate. The clearest opportunity lies in converting its strong mid-list recommendation presence into first-position wins across high-intent discovery prompts.
Who This Report Is For
This report is for brand, growth, and digital strategy leaders at 23andMe and for category analysts tracking how AI systems shape buyer choice in the DNA testing kits market.
Report Card
Field | Value |
|---|---|
Report type | AI Company Market Strategy Report |
Target company | 23andMe |
Category / market studied | DNA Testing Kits |
Reporting month | September 2026 |
AI platforms tracked | 6 (ChatGPT, Copilot, Gemini, Perplexity, AI Overviews, AI Mode) |
Public high-intent clusters | 1 |
AI observations analyzed | 614 |
Competitors tracked | 10 |
Executive Summary
23andMe holds a strong but eroding position in AI-generated recommendations for DNA testing kits. The September 2026 benchmark shows valid recommendation coverage of 65.15%, down 5.9 points from July 2026's 71.0%, a decline beyond normal variation across the three-month series. The brand remains the second-most-recommended option in the category, but the gap to leader AncestryDNA has widened as 23andMe's top-three placement fell from 67.5% to 58.14% over the same period.
The brand's raw presence remains exceptionally high. 23andMe appeared in 95.6% of qualified observations in September, with 438 positive mentions, 135 neutral mentions, and 14 negative mentions across 614 total observations. This is a brand that AI systems consistently surface and discuss. The challenge is not visibility; it is recommendation conversion and placement depth.
The strongest cluster for 23andMe is the brand recommendation and discovery class, which accounts for all qualified observations in the current public benchmark. Within that cluster, the brand's average recommended rank of 2.17 shows it is frequently placed near the top of recommendation lists. The weakest signal is rank-one performance: 23andMe was the first-listed recommendation in only 8 of 614 observations, a 1.3% rate that is dramatically below AncestryDNA's 67.1%.
Platform signals vary meaningfully. 23andMe performs strongest on Perplexity, where it holds a 72.13% top-three rate and a 6.56% rank-one rate, and on ChatGPT, where top-three placement reaches 72.06%. The clearest platform gap appears on Gemini, where the brand records a 54.65% top-three rate and zero rank-one placements across 86 observations.
The benchmark evidence suggests 23andMe is being recommended often but positioned as a strong alternative rather than the default choice. AI systems appear to treat AncestryDNA as the primary answer and 23andMe as the leading secondary option, a pattern that limits the brand's share of first-position recommendations where buyer attention is highest.
What 23andMe Is Winning
Questions This Section Answers
- Where does 23andMe hold its strongest recommendation positions versus competitors?
- Which platform shows the best signs of first-position conversion for 23andMe?
23andMe holds the second-highest valid recommendation coverage in the category at 65.15%, ahead of MyHeritage DNA by 3.7 points and FamilyTreeDNA by 6.2 points. This is a durable upper-tier position that no challenger has meaningfully threatened in the September benchmark.
The brand's raw mention presence of 95.6% means AI systems almost always include 23andMe when discussing DNA testing kits. This near-universal presence provides a foundation for recommendation growth that most competitors cannot match.
Sentiment framing is strongly positive. 23andMe records a net sentiment score of 0.7223, with positive mentions outnumbering negative mentions by a wide margin. The brand is rarely discussed in cautionary or critical terms, which keeps the door open for stronger recommendation placement.
On Perplexity, 23andMe achieves its strongest platform performance with a 72.13% top-three rate and a 6.56% rank-one rate, the brand's best first-position showing across all tracked surfaces.
Where 23andMe Has the Clearest AI Visibility Gaps
Questions This Section Answers
- How large is the gap between 23andMe's recommendation coverage and its rank-one placement?
- Which tracked platforms consistently fail to place 23andMe first?
The most significant gap is first-position recommendation placement. 23andMe holds 65.15% valid recommendation coverage but converts only 1.3% of observations into rank-one recommendations. AncestryDNA, by contrast, converts 73.3% coverage into a 67.1% rank-one rate. This means that when AI systems recommend 23andMe, they almost always place it behind AncestryDNA rather than ahead of it.
The brand's top-three rate of 58.14% is 7 points below its valid recommendation coverage, indicating that a meaningful share of 23andMe recommendations appear in positions four through ten. The average recommended rank of 2.17 shows the brand is close to the top of lists, but not consistently occupying the first slot where buyer selection bias is strongest.
Copilot presents a specific weakness. Across 83 observations, 23andMe achieved a 53.01% top-three rate and zero rank-one placements. Gemini shows a similar pattern with zero rank-one placements across 86 observations. These platforms treat 23andMe as a consistent secondary recommendation but rarely elevate it to the default answer.
The decline across the three-month series compounds these placement issues. Top-three placements fell from 401 in July to 357 in September, and rank-one placements fell from 18 to 8. The brand is losing ground in the positions that matter most for buyer consideration.
Biggest Opportunity
Questions This Section Answers
- What is the most addressable weakness in 23andMe's AI recommendation profile?
- Which surfaces offer the most receptive path toward first-position wins?
The clearest opportunity for 23andMe is converting its strong secondary recommendation position into first-position wins on high-intent discovery prompts. The brand is already present in nearly every AI response and is recommended in nearly two-thirds of qualified observations. The gap between being recommended and being the first-listed recommendation is the single largest addressable weakness in the brand's AI visibility profile.
Closing this gap requires understanding which prompt themes currently push 23andMe below AncestryDNA and which surfaces are most resistant to rank-one placement. The platform data suggests Perplexity and ChatGPT are the most receptive surfaces, while Copilot and Gemini present the largest conversion challenges. Targeted work on the prompt, page, and citation layers that shape first-position decisions could move 23andMe from a strong alternative to the default recommendation in a meaningful share of discovery conversations.
Competitive Landscape
Questions This Section Answers
- Where does 23andMe stand among tracked DNA testing kit brands on placement metrics?
- Which competitors pose the strongest threat despite lower top-three rates?
AncestryDNA holds dominant recommendation-stage strength in the DNA testing kits category, with 23andMe positioned as the strongest challenger. The upper tier is completed by MyHeritage DNA and FamilyTreeDNA, while the remaining tracked brands hold substantially weaker recommendation positions.
Brand | Top-3 rate | Rank-1 rate | Avg recommended rank | Sentiment |
|---|---|---|---|---|
AncestryDNA | 70.03% | 67.10% | 1.05 | 0.8069 |
23andMe | 58.14% | 1.30% | 2.17 | 0.7223 |
MyHeritage DNA | 46.91% | 1.47% | 2.96 | 0.8260 |
FamilyTreeDNA | 23.29% | 0.49% | 3.54 | 0.8372 |
6.51% | 1.30% | 3.84 | 0.8733 | |
Living DNA | 1.95% | 0.16% | 4.32 | 0.7081 |
0.65% | 0.00% | 4.00 | 0.8077 | |
tellmeGen | 0.65% | 0.16% | 3.67 | 0.4500 |
CRI Genetics | 0.00% | 0.00% | 5.00 | 0.3333 |
0.00% | 0.00% | 5.00 | 1.0000 |
Average recommended rank covers rank-eligible recommendations only.
The table shows 23andMe holding a clear second-place position in top-three rate, but the rank-one gap to AncestryDNA is substantial. MyHeritage DNA and FamilyTreeDNA trail 23andMe in top-three placement but hold comparable or better sentiment scores, suggesting the competitive threat is not in framing quality but in placement share.
Prompt Evidence
Questions This Section Answers
- How does 23andMe's recommendation placement vary by platform and prompt?
- On which prompt-surface combinations does 23andMe fail to reach the first position?
Perplexity / Brand Recommendation Prompt: "Which DNA test is best for ancestry?" Result: 23andMe appears in the top three in 72.13% of Perplexity observations and achieves its strongest rank-one rate of 6.56% on this surface.
ChatGPT / Brand Recommendation Prompt: "What is the best DNA ancestry kit to buy?" Result: 23andMe reaches a 72.06% top-three rate on ChatGPT, but rank-one placement remains limited at 2.94%, with AncestryDNA taking the first position in most responses.
Gemini / Brand Recommendation Prompt: "best genetic testing" Result: 23andMe appears in 84.88% of Gemini responses but records zero rank-one placements, consistently positioned behind AncestryDNA in the recommendation order.
What CiteWorks Studio Would Do Next
Phase 1: AI Market Discovery Audit Map the specific prompt themes where 23andMe loses first-position placement to AncestryDNA and identify which competitor captures the recommendation when 23andMe is displaced.
Phase 2: Recommendation Readiness Plan Prioritize the high-intent discovery prompts where 23andMe already holds top-three presence and build a targeted plan to convert those positions into rank-one recommendations.
Phase 3: Owned Answer Layer Buildout Develop owned content that directly answers the discovery and evaluation questions where AI systems currently default to AncestryDNA, giving AI platforms clearer evidence for first-position placement.
Phase 4: Citation / Authority Layer Development Strengthen the external source footprint that AI systems cite when forming DNA testing kit recommendations, focusing on the comparison and evaluation content that shapes placement decisions.
Phase 5: Monthly AI Visibility and Recommendation Tracking Track 23andMe's top-three and rank-one rates monthly across all six surfaces to measure whether placement improvements follow the citation and content work.
Why This Matters
AI-generated recommendations are becoming the first filter in buyer decisions about DNA testing kits. When a prospective customer asks an AI assistant which kit to buy, the first brand listed carries disproportionate weight in the final choice. 23andMe is present in nearly every AI response and is recommended in most of them, but it is rarely the first answer.
The next move for 23andMe is not broader visibility. The brand already has that. The work is targeted correction of the prompt, page, and citation layers that determine whether AI systems present 23andMe as the default choice or as the leading alternative behind AncestryDNA. Closing that gap would convert the brand's strong presence into the first-position recommendations where buyer decisions are actually formed.
Core Metrics
Metric | Value |
|---|---|
Mentions | 587 |
Valid recommendations | 400 |
Top 3 recommendation count | 357 |
Rank #1 recommendation count | 8 |
Average recommended rank | 2.17 |
Positive mentions | 438 |
Neutral mentions | 135 |
Negative mentions | 14 |
Raw mention presence rate | 95.60% |
Valid recommendation coverage | 65.15% |
Top 3 recommendation rate | 58.14% |
Rank #1 recommendation rate | 1.30% |
Net sentiment score | 0.7223 |
Strongest cluster by recommendation behavior | Best DNA Testing Kits, Discovery & Evaluation |
Strongest platform by recommendation behavior | Perplexity |
Sentiment Score
Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions
For 23andMe, this calculation is (438 × 1 + 135 × 0 + 14 × -1) / 587, producing a net sentiment score of 0.7223.
This score matters because unclassified mention counts are misleading. A brand can appear in thousands of AI responses and still be discussed in ways that do not support purchase consideration. Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, neutral reference, cautionary mention, and competitor-displaced mention are not equal. Counting all mentions as wins is bad measurement. Classified sentiment is required before interpreting AI visibility, because the framing of a mention determines whether it helps or hurts the brand at the decision moment.
Sentiment by Platform
Platform | Mentions | Positive | Neutral | Negative | Sentiment Score | Readout |
|---|---|---|---|---|---|---|
ChatGPT | 67 | 52 | 11 | 4 | 0.7164 | Present, but not recommendation-led |
Copilot | 82 | 62 | 13 | 7 | 0.6707 | Present, but not recommendation-led |
Gemini | 73 | 56 | 17 | 0 | 0.7671 | Present as context, not recommendation |
Perplexity | 58 | 50 | 8 | 0 | 0.8621 | Strongest public recommendation signal |
AI Overviews | 157 | 121 | 33 | 3 | 0.7516 | Present, but not recommendation-led |
AI Mode | 150 | 97 | 53 | 0 | 0.6467 | Present as context, not recommendation |
Methodology
- This report is based on the LLM Authority Index AI Market Discovery Index for the DNA Testing Kits category, a neutral industry benchmark tracking how AI search and chat surfaces present brands. It is not a client implementation case study.
- The reporting window is September 2026, with baseline comparisons to July 2026 and August 2026 where the three-month series provides context.
- Six AI/search surface families were tracked: ChatGPT, Copilot, Gemini, Perplexity, AI Overviews, and AI Mode.
- The benchmark began with 800 source prompt-surface observations in September 2026, of which 796 were relevant to the category and 4 were irrelevant.
- After qualification, 614 observations formed the public denominator for all brand-level metrics.
- The competitor universe included 10 tracked brands: AncestryDNA, 23andMe, African Ancestry, CRI Genetics, FamilyTreeDNA, Health Nucleus, Living DNA, MyHeritage DNA, Nebula Genomics, and tellmeGen.
- All qualified observations fell into the brand recommendation buyer-intent class, representing discovery and consideration. No qualified observations were recorded in pricing and value or multi-brand comparison classes.
- A mention is defined as any appearance of a brand in a qualified AI response, regardless of framing or recommendation status.
- A valid recommendation is defined as a positive, rank-eligible recommendation in which the brand is actively recommended rather than merely referenced, compared, or listed.
- The public benchmark records metric movements but does not by itself establish the cause of those movements. Company-level analysis is required to explain why changes occurred.
- Brands with fewer than 10 valid recommendations can move meaningfully with a change of just a few prompts; percentage shifts for tellmeGen, CRI Genetics, and Health Nucleus should be treated with caution.
- Source presence in AI responses is evidence about the information environment. It is not automatically proof that a source caused a recommendation outcome.
See How AI Is Recommending Your Brand
The public benchmark shows where 23andMe stands in AI-generated recommendations for DNA testing kits. A company-level AI visibility audit goes deeper, mapping the specific prompts, surfaces, competitors, and evidence sources that determine whether 23andMe is recommended first, second, or not at all. Understanding those patterns is the first step toward converting strong presence into first-position recommendations.
/ Take the next step
Want to Understand Your AI Citation Footprint?
We start every engagement with a full audit of how AI systems reference your brand today.
Measurable, Repeatable Programme
Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge
Citation Architecture Review
Identify which high-authority community sources are and aren't working in your favour across AI platforms.
AI Visibility Audit
Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.
/ Learn More
Understanding AI search visibility.
AI search experiences create answers by pulling information from many places online and summarizing it into a single response.


